137.73 EUR +0.78 +0.57%
Official Close 3/17/2023 STU


Carl Zeiss Meditec Historical Prices

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Carl Zeiss Meditec Analyst Opinions

Carl Zeiss Meditec Estimates* in EUR

  2023 2024 2025 2026 2027
Revenue 2,098 2,289 2,519 2,696 2,883
Dividend 1.12 1.23 1.26 1.36 -
Dividend Yield (in %) 0.81 % 0.89 % 0.91 % 0.98 % -
EPS 3.28 3.72 4.27 5.11 5.32
P/E Ratio 42.04 37.13 32.29 27.00 25.94
EBIT 418 475 544 613 656
EBITDA 489 550 620 688 769
Net Profit 291 327 374 438 472
Net Profit Adjusted 296 334 385 439 474
Pre-Tax Profit - - - - -
Net Profit (Adjusted) 422 479 542 611 677
EPS (Non-GAAP) ex. SOE - - - - -
EPS (GAAP) 3.26 3.70 4.22 4.76 5.28
Gross Income 1,225 1,340 1,483 1,653 1,863
Cash Flow from Investing -76 -85 -83 -83 -110
Cash Flow from Operations 332 387 437 496 519
Cash Flow from Financing -112 -111 -97 -115 -149
Cash Flow per Share 3.58 4.03 4.59 - -
Free Cash Flow 261 308 356 517 589
Free Cash Flow per Share 2.76 3.09 3.53 - -
Book Value per Share 24.31 26.79 29.97 - -
Net Debt -617 -750 -831 271 -1,029
Research & Development Exp. 322 342 372 397 433
Capital Expenditure 69 75 80 58 50
Selling, General & Admin. Exp. 490 530 573 600 -
Shareholder’s Equity 2,180 2,411 2,714 3,018 3,349
Total Assets 2,961 3,197 3,477 3,872 4,206
  Previous Quarter Current Quarter
ending 03/31/23
Next Quarter
ending 06/30/23
Current Year
ending 09/30/23
Next Year
ending 09/30/24
Earnings Estimates
No. of Analysts - 1 1 11 11
Average Estimate - 0.785 EUR 1.073 EUR 3.282 EUR 3.716 EUR
Year Ago - 1.010 EUR - 3.290 EUR 3.282 EUR
Publish Date - 2/10/2023 5/9/2023 - -
Revenue Estimates
No. of Analysts - 1 1 11 11
Average Estimate - 509 EUR 564 EUR 2,098 EUR 2,289 EUR
Year Ago - 445 EUR - 1,903 EUR 2,098 EUR
Publish Date - 2/10/2023 5/9/2023 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Carl Zeiss Meditec Dividend Calendar

Date Name Dividend *yield Currency
2022 Carl Zeiss Meditec AG 1.10 1.02 EUR
2021 Carl Zeiss Meditec AG 0.90 0.54 EUR
2020 Carl Zeiss Meditec AG 0.50 0.46 EUR
2019 Carl Zeiss Meditec AG 0.65 0.62 EUR
2018 Carl Zeiss Meditec AG 0.55 0.76 EUR
2017 Carl Zeiss Meditec AG 0.55 1.25 EUR
2016 Carl Zeiss Meditec AG 0.42 1.23 EUR
2015 Carl Zeiss Meditec AG 0.38 1.52 EUR
2014 Carl Zeiss Meditec AG 0.40 1.74 EUR
2013 Carl Zeiss Meditec AG 0.45 2.04 EUR
2012 Carl Zeiss Meditec AG 0.40 2.01 EUR
2011 Carl Zeiss Meditec AG 0.30 2.25 EUR
2010 Carl Zeiss Meditec AG 0.22 1.90 EUR
2009 Carl Zeiss Meditec AG 0.18 1.78 EUR
2009 Carl Zeiss Meditec AG 0.18 1.62 EUR
2008 Carl Zeiss Meditec AG 0.18 1.78 EUR
2007 Carl Zeiss Meditec AG 0.16 1.04 EUR
2006 Carl Zeiss Meditec AG 0.14 0.76 EUR
2005 Carl Zeiss Meditec AG 0.16 1.02 EUR
2004 Carl Zeiss Meditec AG - - EUR
2003 Carl Zeiss Meditec AG - - EUR
2002 Carl Zeiss Meditec AG - - EUR
2001 Carl Zeiss Meditec AG - - EUR
2000 Carl Zeiss Meditec AG - - EUR
1999 Carl Zeiss Meditec AG - - EUR
*Yield of the Respective Date

Carl Zeiss Meditec AG Calendar

Event Estimate Info Date
Annual General Meeting - Annual General Meeting 03/22/2023
Earnings Report 1.073 EUR Q2 2023 Earnings Release 05/09/2023
Earnings Report - Q3 2023 Earnings Release 08/04/2023
Earnings Report - Q4 2023 Earnings Release 12/12/2023
Earnings Report - Q1 2024 Earnings Release 02/09/2024
Earnings Report - Q2 2024 Earnings Release 05/06/2024
Earnings Report - Q3 2024 Earnings Release 08/09/2024
Earnings Report - Q4 2024 Earnings Release 12/06/2024

Carl Zeiss Meditec AG Past Events

Event Actual EPS Info Date
Earnings Report 0.570 EUR Q1 2023 Earnings Release 02/10/2023
Shareholders' Meeting - - 03/30/2022

Carl Zeiss Meditec Profile

Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on July 2002 and is headquartered in Jena, Germany.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
2
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Carl Zeiss Meditec Shareholder

Owner in %
Carl-Zeiss-Stiftung 59.14
Freefloat 40.86
American Funds Capital World Growth & Income Fund 1.29
American Funds New Perspective Fund 0.97
American Funds New World Fund 0.88
Groupama Avenir EUR 0.83
American Funds EuroPacific Growth Fund 0.81
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Carl Zeiss Meditec Management

Name Job
Markus Weber Chairman-Management Board
Karl Lamprecht Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Tania von der Goltz Deputy Chairman-Supervisory Board
Sebastian Frericks Director-Investor Relations
Rene Denner Member-Supervisory Board
Brigitte Koblizek Member-Supervisory Board
Jeffrey Marx Member-Supervisory Board
Peter Kameritsch Member-Supervisory Board
Christian Müller Member-Supervisory Board
Isabel de Paoli Member-Supervisory Board
Torsten Reitze Member-Supervisory Board